Coronary artery disease in orthotopic liver transplantation: Pretransplant assessment and management

Liver Transplantation

Volumn 16, Issue 5, 2010, Pages 550-557

  Ehtisham, Javed ^a   Altieri, Mario ^a   Salamé, Ephrem ^a   Saloux, Eric ^a   Ollivier, Isabelle ^a   Hamon, Martial ^a,b  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROPRANOLOL; TICLOPIDINE;

ANGIOCARDIOGRAPHY; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; HEART SURGERY; HUMAN; LIVER DISEASE; LIVER GRAFT REJECTION; LIVER SURGERY; LIVER TRANSPLANTATION; PERCUTANEOUS CORONARY INTERVENTION; PORTAL HYPERTENSION; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; REVIEW; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY;

COMORBIDITY; CORONARY ARTERY DISEASE; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; PREOPERATIVE CARE; PREVALENCE; RISK FACTORS;

EID: 77951740918     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22035     Document Type: Review

References (84)

1. Cicognani C, Malavolti M, Morselli-Labate AM, Zamboni L, Sama C, Barbara L. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Arch Intern Med 1997;157:792-796. (Pubitemid 27164455)
2. Lee SS. Cardiac abnormalities in liver cirrhosis. West J Med 1989;151:530-535.
3. Blei AT, Mazhar S, Davidson CJ, Flamm SL, Abecassis M, Gheorghiade M. Hemodynamic evaluation before liver transplantation: insights into the portal hypertensive syndrome. J Clin Gastroenterol 2007;41(suppl 3):S323-S329. (Pubitemid 350059458)
4. Vanecek R. Atherosclerosis and cirrhosis of the liver. Bull World Health Org 1976;53:567-570.
5. Otsubo R, Higuchi Mde L, Gutierrez PS, Benvenuti LA, Massarollo PC, Costa AL, et al. Influence of chronic liver disease on coronary atherosclerosis vulnerability features. Int J Cardiol 2006;109:387-391.
6. Kadayifci A, Tan V, Ursell PC, Merriman RB, Bass NM. Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies. J Hepatol 2008; 49:595-599.
7. Ong J, Younossi ZM, Reddy V, Price LL, Gramlich T, Mayes J, et al. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease. Liver Transpl 2001;7:797-801. (Pubitemid 32851301)
8. Carey WD, Dumot JA, Pimentel RR, Barnes DS, Hobbs RE, Henderson JM, et al. The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation 1995;59:859-864.
9. Morris JJ, Hellman CL, Gawey BJ, Ramsay MA, Valek TR, Gunning TC, et al. Case 3-1995. Three patients requiring both coronary artery bypass surgery and orthotopic liver transplantation. J Cardiothorac Vasc Anesth 1995;9:322-332.
10. Donovan CL, Marcovitz PA, Punch JD, Bach DS, Brown KA, Lucey MR, et al. Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation 1996;61:1180-1188.
11. Plotkin JS, Benitez RM, Kuo PC, Njoku MJ, Ridge LA, Lim JW, et al. Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation. Liver Transpl Surg 1998;4:253-257.
12. Tiukinhoy-Laing SD, Rossi JS, Bayram M, De Luca L, Gafoor S, Blei A, et al. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation. Am J Cardiol 2006;98:178-181. (Pubitemid 43975507)
13. Fili D, Vizzini G, Biondo D, Pietrosi G, Volpes R, Palazzo U, et al. Clinical burden of screening asymptomatic patients for coronary artery disease prior to liver transplantation. Am J Transplant 2009;9:1151-1157.
14. Safadi A, Homsi M, Maskoun W, Lane KA, Singh I, Sawada SG, et al. Perioperative risk predictors of cardiac outcomes in patients undergoing liver transplantation surgery. Circulation 2009;120:1189-1194.
15. McAvoy N, Kochar N, McKillop G, Newby D, Hayes P. Prevalence of coronary artery calcification in patients undergoing assessment for orthotopic liver transplantation. Liver Transpl 2008;14:1725-1731.
16. Zetterman RK, Belle SH, Hoofnagle JH, Lawlor S, Wei Y, Everhart J, et al. Age and liver transplantation: a report of the Liver Transplantation Database. Transplantation 1998;66:500-506. (Pubitemid 28415378)
17. Bilbao I, Dopazo C, Lazaro JL, Castells L, Escartin A, Lopez I, et al. Our experience in liver transplantation in patients over 65 yr of age. Clin Transplant 2008;22:82-88. (Pubitemid 351150007)
18. Plotkin JS, Scott VL, Pinna A, Dobsch BP, De Wolf AM, Kang Y. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl 1996;2:426-430. (Pubitemid 26386861)
19. Glauser FL. Systemic hemodynamic and cardiac function changes in patients undergoing orthotopic liver transplantation. Chest 1990;98:1210-1215.
20. Vogt DP, Henderson JM, Carey WD, Barnes D. The longterm survival and causes of death in patients who survive at least 1 year after liver transplantation. Surgery 2002;132:775-780. (Pubitemid 35247344)
21. Pruthi J, Medkiff KA, Esrason KT, Donovan JA, Yoshida EM, Erb SR, et al. Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl 2001;7:811-815. (Pubitemid 32851304)
22. Sheiner PA, Magliocca JF, Bodian CA, Kim-Schluger L, Altaca G, Guarrera JV, et al. Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation 2000;69:781-789. (Pubitemid 30174097)
23. Bianchi G, Marchesini G, Marzocchi R, Pinna AD, Zoli M. Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression. Liver Transpl 2008; 14:1648-1654.
24. Canzanello VJ, Schwartz L, Taler SJ, Textor SC, Wiesner RH, Porayko MK, et al. Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506). Liver Transpl Surg 1997;3:1-9. (Pubitemid 27043785)
25. Richards J, Gunson B, Johnson J, Neuberger J. Weight gain and obesity after liver transplantation. Transpl Int 2005;18:461-466. (Pubitemid 41726882)
26. Everhart JE, Lombardero M, Lake JR, Wiesner RH, Zetterman RK, Hoofnagle JH. Weight change and obesity after liver transplantation: incidence and risk factors. Liver Transpl Surg 1998;4:285-296. (Pubitemid 28323748)
27. Neal DAJ, Tom BDM, Luan JA, Wareham NJ, Gimson AES, Delriviere LD, et al. Is there disparity between risk and incidence of cardiovascular disease after liver transplant? Transplantation 2004;77:93-99.
28. Perkins JD. Metabolic syndrome: a new view of some familiar transplant risks. Liver Transpl 2006;12:485-486.
29. Laryea M, Watt KD, Molinari M, Walsh MJ, McAlister VC, Marotta PJ, et al. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events. Liver Transpl 2007;13:1109-1114. (Pubitemid 47305029)
30. Murray KF, Carithers RL Jr. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology 2005;41:1407-1432.
31. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 2007;50:e159-e241.
32. Guckelberger O, Mutzke F, Glanemann M, Neumann UP, Jonas S, Neuhaus R, et al. Validation of cardiovascular risk scores in a liver transplant population. Liver Transpl 2006;12:394-401.
33. Fouad TR, Abdel-Razek WM, Burak KW, Bain VG, Lee SS. Prediction of cardiac complications after liver transplantation. Transplantation 2009;87:763-770.
34. Appleton CP, Hurst RT, Lee KS, Reuss C, Hentz JG. Long-term cardiovascular risk in the orthotopic liver transplant population. Liver Transpl 2006;12:352-355.
35. Davidson CJ, Gheorghiade M, Flaherty JD, Elliot MD, Reddy SP, Wang NC, et al. Predictive value of stress myocardial perfusion imaging in liver transplant candidates. Am J Cardiol 2002;89:359-360. (Pubitemid 34113805)
36. Kryzhanovski VA, Beller GA. Usefulness of preoperative noninvasive radionuclide testing for detecting coronary artery disease in candidates for liver transplantation. Am J Cardiol 1997;79:986-988.
37. Plotkin JS, Johnson LB, Rustgi V, Kuo PC. Coronary artery disease and liver transplantation: the state of the art. Liver Transpl 2000;6(suppl 1):S53-S56. (Pubitemid 30485868)
38. Plevak DJ. Stress echocardiography identifies coronary artery disease in liver transplant candidates. Liver Transpl Surg 1998;4:337-339. (Pubitemid 28323755)
39. Findlay JY, Keegan MT, Pellikka PP, Rosen CB, Plevak DJ. Preoperative dobutamine stress echocardiography, intraoperative events, and intraoperative myocardial injury in liver transplantation. Transplant Proc 2005;37:2209-2213.
40. Tsutsui JM, Mukherjee S, Elhendy A, Xie F, Lyden ER, O'Leary E, et al. Value of dobutamine stress myocardial contrast perfusion echocardiography in patients with advanced liver disease. Liver Transpl 2006;12:592-599. (Pubitemid 44809644)
41. Harinstein ME, Flaherty JD, Ansari AH, Robin J, Davidson CJ, Rossi JS, et al. Predictive value of dobutamine stress echocardiography for coronary artery disease detection in liver transplant candidates. Am J Transplant 2008;8:1523-1528. (Pubitemid 351989500)
42. Williams K, Lewis JF, Davis G, Geiser EA. Dobutamine stress echocardiography in patients undergoing liver transplantation evaluation. Transplantation 2000;69:2354-2356. (Pubitemid 30409002)
43. Umphrey LG, Hurst RT, Eleid MF, Lee KS, Reuss CS, Hentz JG, et al. Preoperative dobutamine stress echocardiographic findings and subsequent short-term adverse cardiac events after orthotopic liver transplantation. Liver Transpl 2008;14:886-892.
44. Diane RA, Rie O, Norman DG, Roberto JG, Jaime B, Guadalupe G-T, et al. Propranolol for the prevention of first esophageal variceal hemorrhage: a lifetime commitment? Hepatology 2001;34:1096-1102.
45. Appleton CP, Hurst RT. Reducing coronary artery disease events in liver transplant patients: moving toward identifying the vulnerable patient. Liver Transpl 2008; 14:1691-1693.
46. Hamon M, Biondi-Zoccai GGL, Malagutti P, Agostoni P, Morello R, Valgimigli M, et al. Diagnostic performance of multislice spiral computed tomography of coronary arteries as compared with conventional invasive coronary angiography: ameta-analysis. J AmColl Cardiol 2006;48:1896-1910. (Pubitemid 44755022)
47. Madan S, Celina Y, David M, Christian Z, John PR, Nathan MB, et al. Safety of cardiac catheterization in patients with end-stage liver disease awaiting liver transplantation. Am J Cardiol 2009;103:742-746.
48. Agostoni P, Biondi-Zoccai GGL, De Benedictis ML, Rigattieri S, Turri M, Anselmi M, et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures: systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol 2004;44:349-356. (Pubitemid 38950594)
49. Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J 2009;157:132-140.
50. Clarke AT, Mills PR. Atorvastatin associated liver disease. Dig Liver Dis 2006;38:772-777.
51. Famularo G, Miele L, Minisola G, Grieco A. Liver toxicity of rosuvastatin therapy. World J Gastroenterol 2007;13: 1286-1288.
52. de Denus S, Spinler SA, Miller K, Peterson AM. Statins and liver toxicity: a meta-analysis. Pharmacotherapy 2004;24:584-591.
53. Law M, Rudnicka AR. Statin safety: a systematic review. Am J Cardiol 2006;97:52C-60C.
54. Onofrei MD, Butler KL, Fuke DC, Miller HB. Safety of statin therapy in patients with preexisting liver disease. Pharmacotherapy 2008;28:522-529. (Pubitemid 351466463)
55. Russo MW, Jacobson IM. How to use statins in patients with chronic liver disease. Cleve Clin JMed 2004;71:58-62. (Pubitemid 39220369)
56. Lowyck I, Fevery J. Statins in hepatobiliary diseases: effects, indications and risks. Acta Gastroenterol Belg 2007;70:381-388. (Pubitemid 351251967)
57. Katznelson S, Wilkinson AH, Kobashigawa JA, Wang XM, Chia D, Ozawa M, et al. The effect of pravastatin on acute rejection after kidney transplantation-a pilot study. Transplantation 1996;61:1469-1474. (Pubitemid 26172708)
58. Kobashigawa JA, Katznelson S, Laks H, Johnson JA, Yeatman L, Wang XM, et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 1995; 333:621-627.
59. Zachoval R, Gerbes AL, Schwandt P, Parhofer KG. Shortterm effects of statin therapy in patients with hyperlipoproteinemia after liver transplantation: results of a randomized cross-over trial. J Hepatol 2001;35:86-91. (Pubitemid 32646229)
60. Wenke K, Meiser B, Thiery J, Nagel D, von Scheidt W, Steinbeck G, et al. Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial. Circulation 1997;96:1398-1402. (Pubitemid 27375328)
61. Taylor PJ, Kubler PA, Lynch SV, Allen J, Butler M, Pillans PI. Effect of atorvastatin on cyclosporine pharmacokinetics in liver transplant recipients. Ann Pharmacother 2004;38:205-208. (Pubitemid 38112227)
62. Imagawa DK, Dawson S III, Holt CD, Kirk PS, Kaldas FM, Shackleton CR, et al. Hyperlipidemia after liver transplantation: natural history and treatment with the hydroxy-methylglutaryl-coenzyme A reductase inhibitor pravastatin. Transplantation 1996;62:934-942.
63. Kakkis JL, Ke B, Dawson S, Maggard M, Si M, Kaldas F, et al. Pravastatin increases survival and inhibits natural killer cell enhancement factor in liver transplanted rats. J Surg Res 1997;69:393-398. (Pubitemid 27317888)
64. Katznelson S, Wang XM, Chia D, Ozawa M, Zhong HP, Hirata M, et al. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro. J Heart Lung Transplant 1998; 17:335-340. (Pubitemid 28196951)
65. Muck W, Neal DA, Boix O, Voith B, Hasan R, Alexander GJ. Tacrolimus/cerivastatin interaction study in liver transplant recipients. Br J Clin Pharmacol 2001;52:213-215. (Pubitemid 32863083)
66. Neal DA, Alexander GJ. Can the potential benefits of statins in general medical practice be extrapolated to liver transplantation? Liver Transpl 2001;7:1009-1014.
67. Ben Ari A, Elinav E, Elami A, Matot I. Off-pump coronary artery bypass grafting in a patient with Child class C liver cirrhosis awaiting liver transplantation. Br J Anaesth 2006;97:468-472. (Pubitemid 44419958)
68. Bizouarn P, Ausseur A, Desseigne P, Le Teurnier Y, Nougarede B, Train M, et al. Early and late outcome after elective cardiac surgery in patients with cirrhosis. Ann Thorac Surg 1999;67:1334-1338. (Pubitemid 29320228)
69. Carr C, Desai J. OPCAB surgery in a cirrhotic hepatocellular carcinoma patient awaiting liver transplant. Ann Thorac Surg 2004;78:1460-1462. (Pubitemid 39303884)
70. Kaplan M, Cimen S, Kut MS, Demirtas MM. Cardiac operations for patients with chronic liver disease. Heart Surg Forum 2002;5:60-65. (Pubitemid 34303097)
71. Wiper A, Schmitt M, Roberts DH. Clopidogrel-induced hepatotoxicity. J Postgrad Med 2008;54:152.
72. Ceylan C, Kirimli O, Akarsu M, Undar B, Guneri S. Early ticlopidine-induced hepatic dysfunction, dermatitis and irreversible aplastic anemia after coronary artery stenting. Am J Hematol 1998;59:260. (Pubitemid 28485512)
73. McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004;351:2795-2804. (Pubitemid 40051903)
74. Shaheen AA, Kaplan GG, Hubbard JN, Myers RP. Morbidity and mortality following coronary artery bypass graft surgery in patients with cirrhosis: a population-based study. Liver Int 2009;29:1141-1151.
75. Filsoufi F, Rahmanian PB, Castillo JG, Karlof E, Schiano TD, Adams DH. Excellent results of cardiac surgery in patients with previous liver transplantation. Liver Transpl 2007;13:1317-1323. (Pubitemid 47457061)
76. Filsoufi F, Salzberg SP, Rahmanian PB, Schiano TD, Elsiesy H, Squire A, et al. Early and late outcome of cardiac surgery in patients with liver cirrhosis. Liver Transpl 2007;13:990-995. (Pubitemid 47163191)
77. Klemperer JD, Ko W, Krieger KH, Connolly M, Rosengart TK, Altorki NK, et al. Cardiac operations in patients with cirrhosis. Ann Thorac Surg 1998;65:85-87.
78. Dillow JR, Larrieu AJ, Fine RH. Emergency coronary revascularization in a liver transplant recipient. Chest 1995;108:1763-1764.
79. Dunton RF, Karlson KJ, Leonardi HK, Jenkins RL, Berger RL. Coronary artery bypass grafting in patients with transplanted livers. Ann Thorac Surg 1994;58: 1054-1058. (Pubitemid 24342429)
80. Prabhakar G, Testa G, Abbasoglu O, Jeyarajah DR, Goldstein RM, Levy MF, et al. The safety of cardiac operations in the liver transplant recipient. Ann Thorac Surg 1998;65:1060-1064. (Pubitemid 28212439)
81. Prifti E, Maccherini M, Capannini G, Sani G. Coronary revascularization after liver transplantation. Eur J Cardiothorac Surg 1998;14:643-644.
82. Lebbinck H, Bouchez S, Vereecke H, Vanoverbeke H, Troisi R, Reyntjens K. Sequential off-pump coronary artery bypass and liver transplantation. Transpl Int 2006; 19:432-434.
83. Manas DM, Roberts DR, Heaviside DW, Chaudhry S, Tocewicz K, Hudson M, et al. Sequential coronary artery bypass grafting and orthotopic liver transplantation: a case report. Clin Transplant 1996;10:320-322. (Pubitemid 26257953)
84. Axelrod D, Koffron A, Dewolf A, Baker A, Fryer J, Baker T, et al. Safety and efficacy of combined orthotopic liver transplantation and coronary artery bypass grafting. Liver Transpl 2004;10:1386-1390. (Pubitemid 39530054)